tickdelta
Sign in

Tickdelta is free for now. Sign up and get Pro free

← Screener

BIIBBiogen

Health care · Biotechnology · Nasdaq
Compare with peers → Embed
Planned sales, announced before they happen

1 trading plan running, 4 Form 144 notices for $905K

10-Q, 10-K and Form 144
Plans running now
1
Priya Singhal, M.D.
Plans adoptedList ↓
7
reported since Apr 25, 2023
Form 144 noticesList ↓
4
$905K the sellers expected to sell

What BIIB's directors and officers said they would sell, before they sold: trading plans the company reports each quarter, and the Form 144 notices sellers file on the day of a planned sale. Most of these sales are routine, such as selling shares from vesting stock awards.

Trading plans

Plans adopted or ended

XBRL, 10-Q and 10-K
InsiderWhatDateSharesRuns toReported in
Lloyd Minor
Director
Adopted 10b5-1 plan May 4, 2026 see filing Aug 7, 2026 10-Q Jul 29, 2026
Priya Singhal, M.D.
EVP, Head of Development
Adopted 10b5-1 plan Apr 30, 2026 see filing Oct 29, 2027 10-Q Jul 29, 2026
Stephen Sherwin
Director
Ended 10b5-1 plan Apr 2, 2025 see filing – 10-Q Jul 31, 2025
Rachid Izzar
EVP, Global Product Strategy and Commercialization
Adopted 10b5-1 plan Mar 12, 2025 see filing Aug 18, 2025 10-Q May 1, 2025
Stephen Sherwin
Director
Adopted 10b5-1 plan Feb 24, 2025 see filing Aug 24, 2025 10-Q May 1, 2025
Priya Singhal, M.D.
EVP, Head of Development
Adopted 10b5-1 plan Feb 18, 2025 see filing Feb 27, 2026 10-Q May 1, 2025
Stephen A. Sherwin
Director
Adopted 10b5-1 plan Nov 7, 2024 see filing May 8, 2025 10-K Feb 12, 2025
What the company wrote
From time to time, our officers (as defined in Rule 16a-1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the fourth quarter of 2024 our officers and directors took the following actions with respect to 10b5-1 trading arrangements: Trading Arrangement Name and Position Action Date Rule 10b5-1 Non-Rule 10b5-1 Total Shares to be Sold Expiration Date Stephen A. Sherwin, Director Adopt 11/7/2024 X — 8,760 05/08/2025
Robin Kramer
Senior Vice President, Chief Accounting Officer
Adopted 10b5-1 plan Nov 13, 2023 see filing 728 days 10-K Feb 14, 2024
What the company wrote
From time to time, our officers (as defined in Rule 16a-1(f)) and directors may enter into Rule 10b5-1 or non-Rule 10b5-1 trading arrangements (as each such term is defined in Item 408 of Regulation S-K). During the fourth quarter of 2023 our officers and directors took the following actions with respect to 10b5-1 trading arrangements: Trading Arrangement Name and Position Action Date Rule 10b5-1 Non-Rule 10b5-1 Total Shares to be Sold Expiration Date Robin Kramer (Senior Vice President, Chief Accounting Officer) Adopt 11/13/2023 X — 1,500 11/10/2025

From the XBRL of the company's 10-Qs and 10-Ks (Regulation S-K Item 408, reported since 2023): 15 filings checked since Apr 25, 2023.

Form 144

Notices of planned sales

Form 144 XML, SEC
FiledSellerSharesValueShares came from10b5-1 planForm 4 sales after
Aug 4, 2026 Minor Lloyd
Director
593 $119K Restricted Stock Vesting adopted May 4, 2026 593 shares from Aug 4, 2026
Aug 3, 2026 Minor Lloyd
Director
593 $121K Restricted Stock Vesting adopted May 4, 2026 1,186 shares from Aug 3, 2026
Feb 9, 2026 Singhal Priya
Officer
2,660 $532K Restricted Stock Vesting adopted Feb 18, 2025 none found
Feb 2, 2026 Singhal Priya
Officer
748 $134K Restricted Stock Vesting adopted Feb 18, 2025 none found

From the Form 144 XML filed with the SEC, since Feb 2, 2026. The value is the seller's estimate on the notice. "Form 4 sales after" matches the seller's Form 4 sales in the 30 days after the notice, by name; Form 4s go back 180 days.

Next Owners →